Cargando…
Co-Stimulatory Receptor Signaling in CAR-T Cells
T cell engineering strategies have emerged as successful immunotherapeutic approaches for the treatment of human cancer. Chimeric Antigen Receptor T (CAR-T) cell therapy represents a prominent synthetic biology approach to re-direct the specificity of a patient’s autologous T cells toward a desired...
Autores principales: | Honikel, Mackenzie M., Olejniczak, Scott H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496564/ https://www.ncbi.nlm.nih.gov/pubmed/36139142 http://dx.doi.org/10.3390/biom12091303 |
Ejemplares similares
-
The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity
por: He, Yuan, et al.
Publicado: (2022) -
T-cell co-stimulatory pathways in autoimmunity
por: Goronzy, Jörg J, et al.
Publicado: (2008) -
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
por: Priceman, Saul J., et al.
Publicado: (2017) -
Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
por: Jeong, Seongju, et al.
Publicado: (2020) -
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
por: Müller, Dafne
Publicado: (2022)